ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) is an immune‐mediated cholestatic liver disease. Liver transplantation (LT) remains the only definitive treatment for patients with advanced disease. However, recurrence of PSC (rPSC) after LT is still a significant clinical challenge.
Isabelle Castro Vitor +10 more
wiley +1 more source
Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literature. [PDF]
Wang C +17 more
europepmc +1 more source
Research trends on autoimmune liver diseases and gut microbiota (1989-2025): a bibliometric and visualization analysis based on the web of science core collection database. [PDF]
Wan Y +10 more
europepmc +1 more source
Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern? [PDF]
Cardinale V, Ridola L, Alvaro D.
europepmc +1 more source
Primary sclerosing cholangitis complicated with ulcerative colitis and double gene mutations of UGT1A1 and SLC25A13: a case report. [PDF]
Shi Y, Chen K, Ye J, Yang M.
europepmc +1 more source
Comments on modeling strategy and data handling in a meta-analysis of anti-integrin αvβ6 for primary sclerosing cholangitis. [PDF]
Montero JA.
europepmc +1 more source
Prevalence and clinical impact of hepatic steatosis on autoimmune liver disease: A systematic review and meta-analysis. [PDF]
Tan JJ +8 more
europepmc +1 more source
Response to Cardinale et al. [PDF]
Sinha SR, Kulkarni C.
europepmc +1 more source
Pediatric Autoimmune Sclerosing Cholangitis: Diagnostic and Therapeutic Challenges. [PDF]
Sucaciu RM +8 more
europepmc +1 more source

